论文部分内容阅读
作者遇到一例君蒂(氟罗沙星)与先抗(头孢哌酮钠)在输注时发生配伍反应。现报道如下。临床资料患者,女,36岁,疑尿路感染,于2002年12月27日在我科输注5%葡萄糖液250ml+先抗(头孢哌酮钠)4g及5%葡萄糖液250ml+君蒂(氟罗沙星)0.2g两组药物。在前组输完续加后组药物时,输液管内出现乳白色浑浊,立即停止输注,患者未出现不良反应。药品君蒂(氟罗沙星)为郑州卓峰制药厂生产[国药准字0.2g(2ml/支),批号X20000577]:先抗(头孢哌酮钠)为江苏恒瑞医药股份有限公司生产[苏卫药准字(1994)2.0g/瓶,批号第394901号];5%葡萄糖液
The author encountered a case of Jun pedicle (fleroxacin) and the first resistance (cefoperazone sodium) compatibility occurs during infusion. Report as follows now. Clinical data Patients, female, 36 years old, suspected urinary tract infection, in our department on December 27, 2002 infusion of 5% glucose solution 250ml + first anti (cefoperazone sodium) 4g and 5% dextrose 250ml + montefloxacin 0.2 g two groups of drugs. In the former group lost after adding the latter group of drugs, opalescent opacity opacity, immediately stop the infusion, the patient did not appear adverse reactions. Drug Junti (fleroxacin) for the production of Zhengzhou Zhuofeng Pharmaceutical [Zhunzi 0.2g (2ml / support), lot number X20000577]: first anti (cefoperazone sodium) Jiangsu Hengrui Pharmaceutical Co., Ltd. production [Su Wei Yaozhunzi (1994) 2.0 g / bottle, Lot No. 394901]; 5% glucose solution